Tilray Exports Medical Cannabis Products to New Zealand for Nationwide Distribution

NEWTON, MA and NEW YORK, NY (SEPTEMBER 19, 2017) – Tikun Olam, a pioneer in cannabis research, and MariMed Inc. (OTCQB:MRMD), a preeminent management company in the U.S. medical cannabis industry, announced an expansion of their licensing agreement for Tikun Olam products to be grown, manufactured and sold through MariMed’s network of managed and affiliated licensed facilities throughout the United States, according to a press release.

This new agreement brings Tikun Olam’s premium cannabis products, years of proprietary, peer-reviewed scientific research and unprecedented clinical data collection to four additional MMJ-legal U.S. states, its most expansive agreement to date. Tikun Olam and MariMed’s relationship began in 2015 with a pilot program in Delaware and marked the first time that U.S. patients had access to the world’s only cannabis strains proven to deliver symptomatic relief for specific conditions including cancer, PTSD, epilepsy, Crohn’s Disease/Colitis, chronic pain and neuropathy, to

... read more at: http://www.cannabisbusinesstimes.com/tilray-exports-medical-cannabis-products-to-new-zealand.aspx

by

Leave a Reply

Your email address will not be published. Required fields are marked *